Step 1 of 2
This educational program will review the mechanistic rationale and emerging clinical data supporting CELMoD development across the multiple myeloma treatment continuum, with emphasis on evolving efficacy and safety data, ongoing investigations, and practical considerations surrounding treatment sequencing and future clinical integration.